National Institute Of General Medical Sciences; Notice of Closed Meetings, 43610-43611 [2019-17988]

Download as PDF 43610 Federal Register / Vol. 84, No. 162 / Wednesday, August 21, 2019 / Notices substance use disorder (SUD) screening data in this request to extend an OMB approval to collect essential, annual data from Title X grantees. Need and Proposed Use of the Information: The Title X Family Planning Program (‘‘Title X program’’ or ‘‘program’’) is the only Federal grant program dedicated solely to providing individuals with comprehensive family planning and related preventive health services (e.g., screening for breast and cervical cancer, sexually transmitted diseases (STDs), and human immunodeficiency virus). By law, priority is given to persons from lowincome families (Section 1006[c] of Title X of the Public Health Service Act, 42 U.S.C. 300). The Office of Population Affairs (OPA) within the Office of the Assistant Secretary for Health administers the Title X program. Likely Respondents: Respondents for this annual reporting requirement are centers that receive funding directly from OPA for family planning services authorized and funded under the Title X Family. This weighted average hour burden accounts for differences in reporting burden by type of grantee agency grantee (e.g., public health department or private agency), as found in the 2009 FPAR Burden Study. For purposes of this estimate, the average hour burden ranges between 39 hours (public health department) and 32 hours (private agency). ANNUALIZED BURDEN HOUR TABLE Number of responses per respondents Average annualized burden per response (hours) Annualized total burden (hours) Type of respondents Form name Grantees ........................................... FPAR ................................................ 93 1 36 3,348 Total ........................................... ........................................................... 93 1 36 3,348 Health, 6701 Rockledge Drive, Room 4122, MSC 7814, Bethesda, MD 20892, 240–498– 7546, diramig@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Terry Clark, Asst. Paperwork Reduction Act Reports Clearance Officer, Office of the Secretary. [FR Doc. 2019–18046 Filed 8–20–19; 8:45 am] BILLING CODE 4150–34–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. jspears on DSK3GMQ082PROD with NOTICES Number of respondents Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflicts: Respiratory Sciences. Date: September 13, 2019. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Ghenima Dirami, PhD., Scientific Review Officer, Center for Scientific Review, National Institutes of VerDate Sep<11>2014 18:13 Aug 20, 2019 Jkt 247001 Dated: August 15, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–17989 Filed 8–20–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute Of General Medical Sciences; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 Panel; Review of NIGMS Support of Competitive Research (SCORE) Award Applications. Date: October 11, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Brian R. Pike, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN18, Bethesda, MD 20892 301–594–3907, pikebr@mail.nih.gov. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of NIGMS Support of Competitive Research (SCORE) Award Applications. Date: November 1, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Manas Chattopadhyay, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN12, Bethesda, MD 20892, 301–827–5320, manasc@mail.nih.gov. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of NIGMS Support of Competitive Research (SCORE) Award Applications. Date: November 20, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Nina Sidorova, Ph.D., Scientific Review Officer, Office of Scientific E:\FR\FM\21AUN1.SGM 21AUN1 Federal Register / Vol. 84, No. 162 / Wednesday, August 21, 2019 / Notices Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN22, Bethesda, MD 20892, 301–594–3663, sidorova@ nigms.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: August 15, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–17988 Filed 8–20–19; 8:45 am] BILLING CODE 4140–01–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1103] Certain Digital Video Receivers and Related Hardware and Software Components; Commission Decision To Review in Part a Summary Determination and To Review in Part a Final Initial Determination; Schedule for Filing Written Submissions on the Issues Under Review and on Remedy, the Public Interest and Bonding U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined to review in part the presiding administrative law judge’s (‘‘ALJ’s’’) summary determination (‘‘SD’’) (Order No. 47) concerning importation and sale after importation and to review in part a final initial determination (‘‘ID’’ or ‘‘final ID’’) finding a violation of section 337 of the Tariff Act of 1930, as amended, with respect to U.S. Patent No. 7,779,011 (‘‘the ’011 patent’’). The Commission requests briefing from the parties on certain issues under review, as set forth in this notice. The Commission also requests briefing from the parties, interested persons, and government agencies on the issues of remedy, the public interest, and bonding. FOR FURTHER INFORMATION CONTACT: Sidney A. Rosenzweig, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 708–2532. Copies of non-confidential jspears on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:13 Aug 20, 2019 Jkt 247001 documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its internet server (https://www.usitc.gov). The public record for this investigation may be viewed on the Commission’s Electronic Docket Information System (‘‘EDIS’’) (https://edis.usitc.gov). Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal, telephone (202) 205–1810. SUPPLEMENTARY INFORMATION: On March 16, 2018, the Commission instituted this investigation based on a supplemented complaint filed on behalf of Rovi Corporation of San Jose, California; Rovi Guides, Inc. of San Jose, California; and Veveo, Inc. of Andover, Massachusetts (collectively, ‘‘Rovi’’); as well as Rovi Technologies Corporation of San Jose, CA. The supplemented complaint alleges violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337 (‘‘section 337’’), based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain digital video receivers and related hardware and software components by reason of infringement of one or more claims of the ’011 patent; and one or more claims of U.S. Patent Nos. 7,937,394 (‘‘the ’394 patent’’); 7,827,585 (‘‘the ’585 patent’’); 9,294,799 (‘‘the ’799 patent’’); 9,396,741 (‘‘the ’741 patent’’); 9,578,363 (‘‘the ’363 patent’’); 9,621,956 (‘‘the ’956 patent’’); and 9,668,014 (‘‘the ’014 patent’’). 83 FR 11792 (Mar. 16, 2018). The Commission’s notice of investigation named as respondents Comcast Corporation of Philadelphia, Pennsylvania; Comcast Cable Communications, LLC of Philadelphia, Pennsylvania; Comcast Cable Communications Management, LLC of Philadelphia, Pennsylvania; Comcast Business Communications, LLC of Philadelphia, Pennsylvania; Comcast Holdings Corporation of Philadelphia, Pennsylvania; and Comcast Shared Services, LLC of Chicago, Illinois (collectively, ‘‘Comcast’’). Id. The Office of Unfair Import Investigations was also named as a party in this investigation. Id. The Commission previously terminated the investigation as to complainant Rovi Technologies PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 43611 Corporation; as to the ’956, ’394, ’014, ’799, and ’363 patents in their entirety; and as to certain claims of the ’011, ’585, and ’741 patents. Order No. 12, unreviewed, Notice (July 24, 2018); Order No. 33, unreviewed, Notice (Sept. 19, 2018); Order 39, unreviewed, Notice (Oct. 25, 2018). On June 3, 2019, the presiding ALJ issued Order No. 47, the subject SD, which, inter alia, granted Rovi’s motions for summary determination as to importation and sale after importation. On June 11, 2019, Comcast filed a petition for review of the SD. On June 18, 2019, Rovi responded to Comcast’s petition. On June 25, 2019, the Commission investigative attorney (‘‘IA’’) responded to Comcast’s petition. On June 4, 2019, the ALJ issued the final ID. On June 17, 2019, Comcast and Rovi each filed a petition for review of the final ID. On June 25, 2019, Comcast and Rovi responded to each other’s petition, and the IA responded to both. In addition, the Commission has received comments from Rovi on the public interest pursuant to Commission Rule 210.50(a)(4). The Commission also received comments from the following organizations in response to the Commission notice soliciting public interest comments, 84 FR 27804 (June 14, 2019): Tea Party Patriots Action; Americans for Limited Government; Frontiers of Freedom Institute; Market Institute; and Conservatives for Property Rights (joined by 60 Plus Association, and Americans for Limited Government). On June 26, 2019, the Commission extended the deadline for whether to review the SD to be commensurate with the deadline for the final ID. On July 24, 2019, the Commission extended the deadline for whether to review the SD and the final ID from August 5, 2019 to August 15, 2019. With respect to the subject SD, having reviewed the record of this investigation, including the SD and the parties’ submissions to the ALJ and to the Commission, the Commission has determined to review in part the SD. In particular, the Commission has determined to review and take no position on whether Comcast’s alleged reimportations satisfy the importation requirement of section 337; the SD made no findings on the issue. The Commission has determined not to review the remainder of the SD. With respect to the subject final ID, having reviewed the record of the investigation, including the final ID and the parties’ submissions to the ALJ and to the Commission, the Commission has determined to review in part the final ID as follows: E:\FR\FM\21AUN1.SGM 21AUN1

Agencies

[Federal Register Volume 84, Number 162 (Wednesday, August 21, 2019)]
[Notices]
[Pages 43610-43611]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17988]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute Of General Medical Sciences; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of NIGMS Support of 
Competitive Research (SCORE) Award Applications.
    Date: October 11, 2019.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Brian R. Pike, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Institute of General Medical 
Sciences, National Institutes of Health, 45 Center Drive, Room 
3AN18, Bethesda, MD 20892 301-594-3907, [email protected].

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of NIGMS Support of 
Competitive Research (SCORE) Award Applications.
    Date: November 1, 2019.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Manas Chattopadhyay, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, 45 Center Drive, 
Room 3AN12, Bethesda, MD 20892, 301-827-5320, [email protected].

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of NIGMS Support of 
Competitive Research (SCORE) Award Applications.
    Date: November 20, 2019.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Nina Sidorova, Ph.D., Scientific Review Officer, 
Office of Scientific

[[Page 43611]]

Review, National Institute of General Medical Sciences, National 
Institutes of Health, 45 Center Drive, Room 3AN22, Bethesda, MD 
20892, 301-594-3663, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives; 93.859, Biomedical Research and 
Research Training, National Institutes of Health, HHS)

    Dated: August 15, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-17988 Filed 8-20-19; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.